ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

538 results

Make your life easier with imaging during primary PCI for acute coronary syndrome

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions highlighting the use of imaging modalities, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), during primary percutaneous coronary interventions (PCI) for acute coronary syndrome. Experts will present and discuss challenging cases, demonstrating how the integration...

Make your life easier with imaging during primary PCI for acute coronary syndrome

Challenges in the treatment of STEMI: unexpected findings and smart solutions

15 May 2024 – From EuroPCR 2024

Challenges in the treatment of STEMI: unexpected findings and smart solutions

Complications in STEMI: sharing is key

15 May 2024 – From EuroPCR 2024

This session covers challenging STEMI complications, including stent dislodgement, anterior STEMI without PCI, LIMA occlusion from iatrogenic dissection, and AMI complicated by left main occlusion. Gain insights on managing these cases and the importance of collaboration in finding optimal solutions.

Complications in STEMI: sharing is key

Management of MINOCA patients

15 May 2024 – From EuroPCR 2024

Management of MINOCA patients

An image is worth a 1,000 words

15 May 2024 – From EuroPCR 2024

An image is worth a 1,000 words

Equity in STEMI management: bridging gaps in STEMI care for women

15 May 2024 – From EuroPCR 2024

This joint session with the Stent - Save a Life! initiative focuses on the unique challenges in STEMI diagnosis and management for women. It explores different pathological processes resulting in STEMI and STEMI mimics in women, and discusses optimal management techniques. The session features perspectives from...

Equity in STEMI management: bridging gaps in STEMI care for women

Upper limb subcalvian artery

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the upper limb subclavian artery. Attendees will have the opportunity to explore various challenging cases, including complex double bifurcation trouble, successful management of a subclavian arterial aneurysm, saddle thrombus at the vertebro-subclavian junction, and more....

Upper limb subcalvian artery

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

PCR's Got Talent - Round 2 - Session 2

15 May 2024 – From EuroPCR 2024

This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).

PCR's Got Talent - Round 2 - Session 2

Targeting inflammation in AMI: a debate

14 May 2024 – From EuroPCR 2024

Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.

Targeting inflammation in AMI: a debate